Your session is about to expire
← Back to Search
Stereotactic Radiotherapy for Breast Cancer
Study Summary
This trial is testing whether preoperative radiation to the breast may help low risk breast cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am planning to undergo a mastectomy.My breast cancer is invasive ductal carcinoma.My tumor is small and found early.My cancer tests show at least 10% ER or PR hormone receptor positivity.I have a condition like Lupus, rheumatoid arthritis, or scleroderma.My tumor's location or my body's shape makes certain treatments not possible.I am female.You are pregnant.My breast cancer is non-invasive.I did not have a clip placed during my biopsy and I do not want one now.I have gone through menopause.I have a breast implant that will be removed before starting the study treatment.My cancer is not HER2 positive according to the latest guidelines.I am receiving or will receive drug treatments before surgery for my cancer.I cannot lie on my stomach comfortably.My cancer has not spread to my lymph nodes.I plan to have surgery to remove my breast tumor but keep my breast, including a sentinel node biopsy.I am 50 years old or older.My MRI shows a clearly outlined tumor.
- Group 1: SBRT to the breast then surgery
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there an enrollment period open for this clinical trial at present?
"Yes, this research is still open for participation. Clinicaltrials.gov indicates that the project was initially published on August 1st 2017 and revised most recently on October 25th 2022."
How many participants are currently included in this clinical trial?
"Affirmative, the data hosted on clinicaltrials.gov indicates that recruitment for this medical trial is underway. It was first posted to the website on August 1st 2017 and last modified October 25th 2022; 40 individuals are sought from two separate sites."
Are there any regulatory approvals for the utilization of Stereotactic Body Radiation SBRT?
"The safety of Stereotactic Body Radiation SBRT was rated a 2 due to the Phase 2 nature of this trial, indicating that while there may be some data supporting its security no studies have evaluated its efficacy."
Who is eligible to partake in this research endeavor?
"This study is currently recruiting 40 individuals diagnosed with breast cancer of ages between 50 and 100. In order to be considered, these patients must meet the following conditions: Age ≥ 50 years old; Invasive ductal carcinoma; Clinically and radiographically T1 tumor Clinically node negative; Clearly demarcated tumour detected by MRI (which may occur after enrolment); Planning for a sentinel lymph node biopsy as part of a breast conserving surgery; Express at least 10% ER/PR receptors, HER2 status in accordance with College of American Pathologists guidelines; Post-menopausal state or equivalent hormone replacement therapy regime if"
Is eligibility for this research restricted to individuals below a certain age threshold?
"In line with the qualifications for joining this clinical trial, participants must be between 50 and 100 years old."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger